Physician
Hematology
Dr. Uday R. Popat, MD
|
|
Give Review
Doctor Uday R. Popat, MD practices Hematology. He attended Baylor College of Medicine. He over the years received 1 awards: "Fellow (FACP)". Uday Popat is a published doctor. He published 101 publications, including: 'Carcinoma of stomach in childhood.' He is registered with Medicare.
Publications
- Autologous hematopoietic stem Cell transplantation in light chain amyloidosis (AL) with renal involvement.
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
- Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
- Indication and management of allogeneic stem Cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.
- Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
- Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
- Enforced fucosylation of cord blood hematopoietic Cells accelerates neutrophil and platelet engraftment after transplantation.
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hemato...
- Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML Cells: enhancement of cytotoxicity with epigenetic modu...
- Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem Cell transplantation for relapsed myeloma.
- Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease.
- Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.
- Can a Female Donor for a Male Recipient Decrease Relapse Rate for Patients with AML Treated with Allogeneic Hematopoietic Stem Cell Transplantation?
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report.
- An update on allogeneic hematopoietic progenitor Cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.
- Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future.
- BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic Leukemia/lymphoma: reduced myelosuppression and GVHD.
- Clinical characteristics and outcomes in patients with Acute promyelocytic leukaemia and hyperleucocytosis.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis.
- Short-term cardiac toxicity of autologous hematopoietic stem Cell transplant for multiple myeloma.
- Second solid Cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.
- Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation.
- Donor Cell-Derived Myelodysplastic Syndrome With Ring Chromosome 7 After Allogeneic Hematopoietic Stem Cell Transplant in 2 Patients With Lymphomas as Primary Disease.
- Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
- ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem Cell transplant.
- Is there an expiration date for a cord blood unit in storage?
- The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
- The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Allogeneic stem cell transplantation as initial salvage for patients with Acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
- Peripheral blood stem Cell yield calculated using preapheresis absolute CD34+ Cell count, peripheral blood volume processed, and donor body weight accurately predicts ...
- Cytarabine, Ki-67, and SOX11 in patients with mantle Cell lymphoma receiving rituximab-containing autologous stem Cell transplantation during first remission.
- Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor Cell mobilization.
- Impact of t(11;14)(q13;q32) on the Outcome of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients w...
- Outcomes of adults with Acute lymphoblastic leukemia (ALL) following relapse post allogeneic hematopoietic stem cell transplantation (HSCT).
- Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem Cell transplant recipients with respiratory syncytial virus infections.
- Tacrolimus-associated posterior reversible encephalopathy Syndrome in hematopoietic allogeneic stem cell transplantation.
- High-dose chemotherapy and Autologous Stem Cell Transplantation For Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
- Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.
- A practical approach for a wide range of Liver iron quantitation using a magnetic resonance imaging technique.
- Incidence and natural history of pure red Cell aplasia in major ABO-mismatched haematopoietic Cell transplantation.
- Cord-blood engraftment with ex vivo mesenchymal-Cell coculture.
- Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic Syndrome: A retrospective case-control study.
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-Cell transplantation in patients with refractory lymphoid malignancies.
- Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with Acute lymphoblastic leukemia.
- Significance of Persistent Cytogenetic Abnormalities at Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell...
- Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular Lymphoma: 12-year results.
- Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Ty...
- Donor leukocyte infusions (DLIs) in recurrent hodgkin lymphoma (HL) following allogeneic stem cell transplantation: ten-year experience at the M.D. anderson Cancer cen...
- A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.
- Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem Cell transplant in relapsed and refractory Hodgkin lymphoma: pre...
- Platelet Recovery Prior to Allogeneic Stem Cell Transplant Predicts Posttransplant Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
- Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem Cell transplantation.
- Outcome of allogeneic hematopoietic stem Cell transplantation in patients with low left ventricular ejection fraction.
- Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem Cell transplantation.
- Carcinoma of stomach in childhood.
- Relapse of Helicobacter pylori infection after different treatment regimens. A 3-month follow-up study.
- Association of peptic ulcer with Helicobacter pylori and the recurrence rate. A three year follow-up study.
- Acute Campylobacter jejuni enteritis in 385 hospitalised patients.
- Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem Cell tra...
- Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of Acute graft-versus-host disease.
- Autologous hematopoietic stem Cell transplantation may reverse renal failure in patients with multiple myeloma.
- Impairment of filgrastim-induced stem Cell mobilization after prior lenalidomide in patients with multiple myeloma.
- Poor hematopoietic stem Cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
- Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
- Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
- Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
- Hematopoietic stem Cell transplantation in patients with sporadic amyotrophic lateral sclerosis.
- The natural history and treatment outcome of blast phase BCR-ABL- Myeloproliferative neoplasms.
- Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-Cell lymphoma treated with...
- Angiogenesis in pulmonary hypertension with myelofibrosis.
- High-dose chemotherapy and autologous hematopoietic progenitor Cell transplantation for non-Hodgkin''s lymphoma in patients >65 years of age.
- Autologous HSCT for advanced MS: is the glass half-empty or really half-full?
- Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in Myeloma patients undergoing an autotransplant.
- Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem Cell transplantation.
- Marrow fibrosis does not account for circulating CD34+ Cells in myelofibrosis with myeloid metaplasia.
- Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem Cell transplantation: risk factors and response to treatment.
- Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk Acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity condi...
- Autologous stem Cell transplantation is safe and feasible in elderly patients with multiple myeloma.
- Idiopathic myelofibrosis without dacryocytes.
- Fixed-dose single agent pegfilgrastim for peripheral blood progenitor Cell mobilisation in patients with multiple myeloma.
- Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk Acute myeloid leukem...
- High levels of circulating CD34 Cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibr...
- Extracorporeal photopheresis for Acute and chronic graft-versus-host disease: does it work?
- Immunotherapy of high-risk Acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell ...
- Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic Leukemia.
- New onset of myelofibrosis in association with pulmonary arterial hypertension.
- Cytomegalovirus (CMV) infections and CMV-specific Cellular immune reconstitution following reduced intensity conditioning allogeneic stem Cell transplantation with Ale...
- Hematopoietic stem Cell transplantation for multiple sclerosis.
- CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem Cell transplantation from HLA matched and one antigen mismatched unrelated donors.
- Constitutive mobilization of CD34+ Cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases.
- Allogeneic hematopoietic stem-Cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.
Schools
U Bombay
Lokmanya Tilak Muni Med CollU Bombay
Baylor College Of Med
Grimsby Dist Genl Hospital
North Middlesex Hospu London
Royal Free Hospital And School Medu London
University TexMD Anderson Canc Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Fellow (FACP)
Education
-
Baylor College of Medicine -
L. Tilak Municipal Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1609971266 | |
| NPPES Provider LastName | POPAT | |
| NPPES Provider FirstName | UDAY | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 437.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609971266 |
| Last Name Of The Provider | POPAT |
| First Name Of The Provider | UDAY |
| View All |
Similar Doctors
|
|
Dr. John M. Carwile, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Giao N. Hoang, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sahba Q. Nadeem, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Harinder S. Juneja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Conklin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vincent Valero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelina Cairo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanam Loghavi, MD |
|
|
Dr. Qaiser Bashir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amado J. Zurita-Saavedra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nina Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny C. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chitra Balasundaram, MD |
|
|
Dr. Georgios Pongas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Annie R. Su, MD
This Doctor is OpenDoctor Recommended.
|